Skip to content
VuFind
Advanced
  • PCSK9 inhibition in statin-int...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
QR Code

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?

Bibliographic Details
Main Authors: Casula, M., Pirillo, A., Norata, Giuseppe, Catapano, A.
Format: Journal Article
Published: Sage Publications 2017
Online Access:http://hdl.handle.net/20.500.11937/58841
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/58841

Similar Items

  • PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
    by: Norata, Giuseppe, et al.
    Published: (2014)
  • Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
    by: Catapano, A., et al.
    Published: (2017)
  • Targeting PCSK9 for hypercholesterolemia
    by: Norata, Giuseppe, et al.
    Published: (2014)
  • Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition
    by: Tibolla, G., et al.
    Published: (2011)
  • PCSK9 inhibitors and dyslipidemia: The clinical evidence
    by: Norata, Giuseppe
    Published: (2014)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips